Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002032089-26-000002
Filing Date
2026-08-03
Accepted
2026-08-03 16:42:34
Documents
1
Period of Report
2026-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1785789751.html 4  
1 FORM 4 wk-form4_1785789751.xml 4 6904
  Complete submission text file 0002032089-26-000002.txt   8438
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Issuer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Seymour Melissa (Reporting) CIK: 0002032089 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06351 | Film No.: 261233759